Latest Breaking News On - Robyn karnauskas - Page 6 : vimarsana.com

AbCellera Biologics Inc. (NASDAQ:ABCL) Q3 2023 Earnings Call Transcript

Operator: Good afternoon, and welcome to AbCellera's Third Quarter 2023 Business Update Conference Call. My name is Kate, and I will facilitate the audio portion of today's interactive broadcast.

Eli Lilly (LLY) Q3 2023 Earnings Call Transcript

LLY earnings call for the period ending September 30, 2023.

Pfizer Inc. (NYSE:PFE) Q3 2023 Earnings Call Transcript

Pfizer Inc. (NYSE:PFE) Q3 2023 Earnings Call Transcript October 31, 2023 Operator: Good day, everyone, and welcome to Pfizer’s Third Quarter 2023 Earnings Conference Call. Today’s call is being recorded. At this time, I would like to turn the call over to Mr. Francesca DeMartino, Chief Investor Relations Officer and Senior Vice President. Please go […]

Pfizer (PFE) Q3 2023 Earnings Call Transcript

PFE earnings call for the period ending September 30, 2023.

Bristol Myers Squibb (BMY) Q3 2023 Earnings Call Transcript

BMY earnings call for the period ending September 30, 2023.

Why Pfizer Stock Slipped Today | The Motley Fool

The company continues to be somewhat out of favor after reducing its guidance late last week.

Truist Financial Remains a Buy on Bristol-Myers Squibb (BMY)

In a report released on September 14, Robyn Karnauskas from Truist Financial maintained a Buy rating on Bristol-Myers Squibb (BMY – Resear...

The FTC cleared Amgen's $27.8 billion Horizon buyout — here's what it means for other massive pharma deals

Some analysts and M&A experts say the settlement agreement doesn’t mean that the FTC will stop baring its teeth at other large buyouts in the industry.

FTC clears Amgen Horizon buyout: What it means for other pharma deals

Some analysts and M&A experts say the settlement agreement doesn't mean that the FTC will stop baring its teeth at other large buyouts in the industry.

The FTC cleared Amgen's $27.8 billion Horizon buyout — here's what it means for other massive pharma deals